Surveillance for vaccine-preventable diseases

Hanna M. Nohynek*, Elizbeth Miller

*Corresponding author for this work

    Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

    1 Citation (Scopus)

    Abstract

    Vaccines are one of the most cost-effective health intervention tools. When developing and before introducing a new vaccine, vaccine-preventable disease (VPD) data are required to estimate the burden of disease, to identify risk groups, and to decide on the appropriate vaccination or vaccine development strategy. Post-introduction data are required to monitor vaccine program performance, to identify remaining pockets of susceptible individuals, and to provide alert signals to identify and control outbreaks. Both clinical and laboratory-based data sources are used. If VPDs are not notifiable by law, and if surveillance data are not available via routine systems, special studies can be performed. Vaccine program-related surveillance includes coordinated monitoring of vaccine coverage and vaccine effectiveness by measuring VPD incidence, hospitalizations, deaths, and vaccine-related adverse events. Epidemiologic methods used are vaccine coverage and serosurveys, cluster sampling, case-control, and cohort studies. This edition first published 2013

    Original languageEnglish
    Title of host publicationInfectious Disease Surveillance
    Subtitle of host publicationSecond Edition
    PublisherJohn Wiley and Sons
    Pages174-186
    Number of pages13
    ISBN (Print)9780470654675
    DOIs
    Publication statusPublished - 12 Mar 2013

    Keywords

    • Case-control
    • Cluster sampling
    • Cohort study
    • Population assessment
    • Serosurveillance
    • Surveillance
    • Vaccine coverage
    • Vaccine effectiveness
    • Vaccine efficacy
    • Vaccine-preventable disease

    Fingerprint

    Dive into the research topics of 'Surveillance for vaccine-preventable diseases'. Together they form a unique fingerprint.

    Cite this